Monday 12 May, 2025 06:44 PM
Site map | Locate Us | Login
   Newgen Software Tech gains after arm secures $1.63 million contract    Man Industries hits the roof after PAT rises nearly 3x YoY to Rs 68 crore in Q4    Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA    Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations    K P R Mill Ltd leads losers in 'A' group    Bajaj Electricals soars after strong Q4 performance    Dr Reddys Lab jumps after Q4 PAT rises 22% YoY    Venkys (India) slides after Q4 PAT tumble 60% YoY to Rs 13 cr    Premier Explosives Ltd leads losers in 'B' group    TFCI jumps after Q4 PAT rises 48% YoY to Rs 30 cr    Volumes soar at C.E. Info Systems Ltd counter    TCS soars after signing digital transformation pact with Oman's largest insurer Dhofar Insurance    Yes Bank gains as Japan's SMBC to acquire 20% stake in landmark deal    Sun Pharmaceutical Industries Ltd eases for fifth straight session    Castrol India Ltd soars 1.91%, rises for third straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Navin Fluorine Intl Q4 PAT rises 35% YoY to Rs 95 cr; declares dividend of Rs 7/sh
12-May-25   11:58 Hrs IST

Revenue from operations rallied 16.44% year on year to Rs 700.94 crore in Q4 FY25, compared with Rs 601.95 crore in Q4 FY24.

Profit before tax (PBT) increased 59.93% YoY to Rs 127.02 crore in Q4 FY25.

Operating EBITDA stood at Rs 178.71 crore in Q4 FY25, registering the growth of 62.39% compared with Rs 110.05 crore in corresponding quarter last year. EBITDA margin improved by 721 Bps to 25.50% in Q4 FY25 as against 18.28% in Q4 FY24.

Revenue from high-performance product (HPP) jumped 10% YoY to Rs 326 crore during the quarter. The growth was driven by higher volumes and improved realizations.

Revenue from specialty chemicals increased 1% YoY to Rs 259 crore in Q4 FY25 with optimal capacity utilization at Dahej & Surat with strong order visibility for FY26. The company said that the 2 new molecules planned supplies to begin in Q1FY26.

In Q4 FY25, revenue from contract development and manufacturing organization (CDMO) zoomed 141% YoY to Rs 115 crore.

Meanwhile, the board of directors has recommended final dividend of Rs 7 per equity share of the face value of Rs 2 each for the financial year 2024-2025 subject to approval of the members of the company at the forthcoming 27 the annual general meeting to be held on 31 July 2025.

Navin Fluorine International belongs to a reputed industrial house of Padmanabh Mafatlal Group in India. It has largest integrated fluorochemicals complex in India. The company primarily focuses on fluorine chemistry - producing refrigeration gases, chemicals, inorganic bulk fluorides, specialty organofluorines and offers Contract Research and manufacturing services.

Shares of Navin Fluorine International shed 0.19% to currently trade at Rs 4,572.90 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40799509
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd